U.S. Economic Growth Slows Amid Global and Domestic ChallengesClemson left guard Trent Howard out with ACL tear for South Carolina gameTHOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE Amgen
can you win on online slots
。
Dyson has slashed the prices of its latest Strawberry Bronze/Blush Pink colorway, just in time for Black Friday. During Dyson’s Black Friday sale, you can buy this new colorway for $100 off all the haircare products it comes in. It is the first time the shade has been on sale since its drop in August. The Black Friday sale as a whole is offering savings up to $300 on select Dyson technology. The special edition Dyson Supersonic Nural hair dryer in Strawberry Bronze/Blush Pink is $399.99 (originally $499 and pictured above). You can also get the hair dryer in the other popular colorways including Vinca Blue/Topaz and Ceramic Patina/Topaz . If you buy the hair dryer you will receive a complimentary sample of Dyson Chitosan pre-style cream at checkout. It has a total value of $59.99. This hair dryer has Nural sensors that automatically adjust airflow and temperature to bring out the shine and help keep your scalp healthy. You can dry your hair up close without the fear of heat damage as the dryer maintains a comfortable temperature, while a scalp protection mode that helps improve scalp moisture for long-lasting shine. Below are the rest of the Strawberry Bronze/Blush Pink products that are in the Dyson Black Friday sale: This is the first multi-styler to use Coanda airflow and will not bring any heat damage to your hair. It’s made for straight and wavy hair and comes with six attachments and three accessories (presentation case, detangling comb and filter cleaning brush). You can dry your hair, curl your hair, shape your hair and smooth your hair with no fly aways. You can also buy this famous straightener on sale in Onyx Black/Gold and Prussian Blue/Rich Copper. Cut your getting ready time down by 25%, Dyson says, when it comes to drying and styling your hair. The powerful airflow will have your hair ready in no time. Get those curls and waves you’ve always wanted but couldn’t create, or smooth your hair if you want it sleek. This technology brings enhanced styling cord free. It also automatically regulates the temperature 100 times per second. Crazy, right? What is the presentation case that comes with Dyson hair products? The presentation case is for protecting and storing your Dyson machine. The case is cushioned with soft fabric to protect the machines from getting dented or scratched. What free gifts are available with a Dyson hair product purchase? If you buy a Dyson Supersonic hair dryer, an Airwrap multi-styler an Airstrait Straightener or a Corrale styler straightener, you will get a complimentary sample of Dyson’s Chitosan pre-style cream. It’s a new Dyson product that uses Triodetic technology to lock in style for long-lasting hold. You will be able to choose between four formulas that are blended with ingredients for the best results for your hair type. You will be able to select the formula at checkout. Total value of $59.99. Additionally, an Airwrap purchase will let you pick two more gifts. With the style cream that comes to a total value of $146.96. The gifts to choose from include a small smoothing brush or a pre-styling dryer attachment. What is the return policy for the Dyson holiday sale? Since it’s the holidays, there is extended holiday returns through Jan. 31, 2025. The product have to have been bought between Nov. 1 and Dec. 25 for it to be returned for free. Refurbished products are final sale and cannot be returned. Dyson Direct will pay for return shipping. More Black Friday deals Walmart has slashed Xbox prices for Black Friday 2024 Nov. 27, 2024, 2:32p.m. UGG Black Friday DSW sale has waterproof boots under $110 (31% off) Nov. 27, 2024, 12:11p.m. Walmart Black Friday Deals include popular 75-inch TV under $380 Nov. 25, 2024, 9:07a.m. HOKA slashes prices of Bondi 8, Clifton 9 in early Black Friday sale Nov. 23, 2024, 3:08p.m. Nordstrom Rack has Michael Kors coat under $100: Black Friday sale Nov. 21, 2024, 4:09p.m. Kaylee Remington is the shopping and entertainment commerce reporter and metro reporter for cleveland.com and The Plain Dealer. Read her work online .Warriors may acquire rough-edged $46 million Hawks center via trade | Sporting News
As a participant in multiple affiliate marketing programs, Localish will earn a commission for certain purchases. See full disclaimer below* Whether you're looking to upgrade your next movie night setup or hoping to game with higher-quality graphics, Cyber Monday is a great time to get the best TVs for a lower price. We rounded up some of the biggest sales going on right now to help you save on your next TV purchase. This TV is a great option for your living room, bedroom or office. Measuring 32 inches, it's decently sized, yet still easy to fit on a table or TV stand. It's also an Amazon Fire TV, so you'll have access to a wide variety of channels and apps. Currently, you can get it for under $100 at 46% off. This TV has been rated five stars over 30,000 times on Amazon, and it's currently on sale for 27% off. It's compatible with both Alexa and Google Assistant and since it's a Roku TV, you'll have access to tons of channels and apps. You can get this great Fire TV for 38% off. It's compatible with 4K Ultra HD, Dolby Digital Plus and Alexa Voice. Amazon is also offering six months free of an MGM+ subscription with the purchase of this TV. This 4K Ultra HD TV is an Amazon bestseller and is currently on sale for 37% off. Enjoy high-quality resolution and a large screen size. This TV also comes with Alexa voice, so you can easily speak commands into the remote. This 85-inch TV is perfect for larger rooms and offers 4K resolution and accurate color representation thanks to Samsung's PurColor technology. Shop it now below $1,000. If you're looking for a larger TV, this Toshiba 75-inch is a great deal. It boasts 4K resolution and both Dolby Vision HDR and Dolby Atmos. Save $200 on this TV for Cyber Monday. Enjoy cinematic 4K TV quality with this 75-inch Amazon Fire TV, which comes with Dolby Vision and Alexa voice control. If you're looking for a large family room TV, this deal is a steal. Get this 100-inch Hisense TV for over $1,000 off right now. Both the QLED display technology and advanced full array local dimming bring you a high-quality viewing experience. Plus, this TV is also compatible with Alexa and Google Assistant. Amazon 50-inch Fire TV for under $300. SAMSUNG 55-inch Class DU6900 Crystal UHD 4K Smart TV for under $300. LG 43-inch Class 4K UHD 2160P webOS Smart TV for just $350. *By clicking on the featured links, visitors will leave Localish.com and be directed to third-party e-commerce sites that operate under different terms and privacy policies. Although we are sharing our personal opinions of these products with you, Localish is not endorsing these products. It has not performed product safety testing on any of these products, did not manufacture them, and is not selling, or distributing them and is not making any representations about the safety or caliber of these products. Prices and availability are subject to change from the date of publication.
NoneAP News Summary at 3:24 p.m. ESTSportradar to Participate in the Morgan Stanley Consumer & Retail Conference